TIANJIN TIANYAO PHARMACEUTICALS CO., LTD.

Other languages Tianjin Tianyao Pharmaceuticals Co., Ltd.

Equities

600488

CNE000001840

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-07 EDT			5-day change	1st Jan Change
4.35 ^CNY	+3.82%		+6.36%	-11.22%

04-26	Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-25	Jinyao Pharma's Unit Gets Approval to Market Compound Ipratropium Bromide Solution	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26
Jinyao Pharma's Unit Gets Approval to Market Compound Ipratropium Bromide Solution	04-25
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
Jinyao Pharma Unit's Fluconazole Chloride Passes Regulatory Evaluation	03-08
Jinyao Pharma Unit's Metoclopramide Hydrochloride Injection Passes Regulatory Evaluation	02-29
Jinyao Pharmaceutical's Drugs Chosen for China's Centralized Procurement Bid	11-08
Jinyao Pharmaceutical Gets Nod to Market Travoprost	11-03
Tianyao Pharma’s Brain Injury Drug Passes Generic Drug Consistency Test	11-02
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27
Jinyao Pharmaceutical Unit's Methylcobalamin Injection Passes Drug Regulator's Evaluation	23-10-23
Jinyao Pharmaceutical Gets Nod to Market Two Raw Drug Materials	23-10-12
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29
Jinyao Pharmaceutical Unit's Tumor Drug Passes Regulatory Evaluation	23-08-01
Jinyao Pharmaceutical Gets Nod for Marketing Application of Raw Drug Material	23-07-14
Tianjin Tianyao Pharma Receives 35 Million Yuan in Government Subsidies	23-05-29
Tianyao Pharma Registers Inhalation Drug	23-05-23
Jinyao Pharmaceutical's Unit Gets Nod to Topical Cream's Registration	23-05-10
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27
Tianyao Pharma Joins Bid to Have Edema Drug Added to China’s Drug Procurement Program	23-03-31
Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Tianjin Tianyao Pharmaceuticals Co., Ltd.

Equities

600488

CNE000001840

Other languages

Filters